| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | WZ-1-84 | GDSC1000 | pan-cancer | AAC | -0.053 | 0.3 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | 0.03 | 0.3 |
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | -0.079 | 0.3 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | -0.076 | 0.3 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.3 |
| mRNA | GDC-0941 | FIMM | pan-cancer | AAC | -0.19 | 0.3 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |